
| Salt Composition: | Cefepime (1000mg) + Tazobactum (125mg) |
| Manufacturer: | Apkavit Lifesciences |
| Storage: | Below 25 degree celcius |
Out of Stock
Have doubts about this medicine?
Have doubts about this medicine?
Appime T 1000mg/125mg Injection is a combination of two antibiotics used to treat various types of bacterial infections. Appime T 1000mg/125mg Injection should only be administered under the supervision of a healthcare professional. Do not miss any scheduled appointments for taking this medicine. The course of the medicine should be completed even if you feel better. The common side effects of this medicine are nausea, vomiting, diarrhea, rashes, etc. You may also experience injection site redness, swelling, and pain that goes away with time. If any of the side effects get aggravated, you must consult your doctor immediately. If you experience any allergic reaction (rashes, itching, swelling, shortness of breath, etc.), you must seek immediate medical help.
Appime T 1000mg/125mg Injection is a combination of two medicines: Cefepime and Tazobactum. Cefepime is an antibiotic. It works by preventing the formation of the bacterial protective covering which is essential for the survival of bacteria in the human body. Tazobactum is a beta-lactamase inhibitor which blocks the action of enzymes produced by bacteria to inactivate cefepime. Addition of Tazobactum reduces resistance and enhances the activity of Cefepime against bacteria.
Your doctor or nurse will give you this medicine. Kindly do not self-administer.
Alcohol
Caution is advised when consuming alcohol with Appime T 1000mg/125mg Injection. Please consult your doctor.
Breastfeed
Appime T 1000mg/125mg Injection is safe to use during breastfeeding. Human studies suggest that the drug does not pass into the breastmilk in a significant amount and is not harmful to the baby.
Pregnancy
Appime T 1000mg/125mg Injection is generally considered safe to use during pregnancy. Animal studies have shown low or no adverse effects to the developing baby; however, there are limited human studies.